A study assessing Dovitinib for renal cell carcinoma
Latest Information Update: 11 Jun 2020
At a glance
- Drugs Dovitinib (Primary)
- Indications Renal cell carcinoma
- Focus Registrational; Therapeutic Use
Most Recent Events
- 09 Jun 2020 According to an Oncology Venture A/S media release, this study is being conducted for a U.S. new drug approval (NDA) filing in renal cell carcinoma (RCC).
- 08 May 2020 New trial record